Cleared Traditional

K082085 - CAPILLARYS IMMUNOTYPING, MODEL 2100

K082085 is an FDA 510(k) clearance for CAPILLARYS IMMUNOTYPING, manufactured by Sebia. The device is a Class 2 Immunology device with product code CFF cleared through the Traditional 510(k) pathway after a 268-day FDA review.

K082085 · Sebia · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
268d
Days
Class 2
Risk

K082085 is an FDA 510(k) clearance for the CAPILLARYS IMMUNOTYPING, MODEL 2100. Classified as Immunoelectrophoretic, Immunoglobulins, (g, A, M) (product code CFF), Class II - Special Controls.

Submitted by Sebia (Norcross, US). The FDA issued a Cleared decision on April 17, 2009 after a review of 268 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sebia devices

FDA 510(k) Submission Details - K082085

510(k) Number K082085 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2008
Decision Date April 17, 2009
Days to Decision 268 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
163d slower than avg
Panel avg: 105d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFF Device Classification - Class 2, Special Controls

Product Code CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)

All 26
Devices cleared under the same product code (CFF) and FDA review panel - the closest regulatory comparables to K082085.
INTERLAB IFE TEST USING G 26 VER. 2.0 INSTRUMENT
K120169 · Grifols USA, LLC · Aug 2012
THE HELENA V8 IMMUNODISPLACEMENT KIT
K111369 · Helena Laboratories Uk, Ltd. · Jun 2012
IMMUNOFIXATION ELECTROPHORESIS TEST USING INTERLAB G26 INSTRUMENT
K103757 · Grifols · Oct 2011
MINICAP IMMUNOTYPING, MODEL: 2300
K082388 · Sebia · Apr 2009
SPIFE IFE-15 PENTAVALENT, MODEL 3456, SPIFE IFE-9 PENTAVALENT KIT, MODEL 3457, SPIFT IFE-6 PENTAVALENT KIT, MODEL 3458
K061069 · Helena Laboratories · Jul 2006
SPIFE 3000 TITAN GEL IGG IEF KIT, MODEL 3389
K024162 · Helena Laboratories · Feb 2003